Prevention of Noise-induced Hearing Loss

Withdrawn before enrolling · Phase 1/Phase 2

Conditions studied: Noise-induced Hearing Loss

In brief

Noise-induced hearing loss affects an estimated 5% of the worldwide population, with 30-40 million Americans exposed to hazardous sound or noise levels regularly. Sources of noise may be occupational, blast noise, or recreational. Trauma to the inner ear can occur through transient hearing loss or permanent hearing loss. Although hearing recovers after temporary transient hearing loss, growing evidence suggests that repeated temporary transient hearing loss may lead to a permanent hearing loss. Currently, there are no treatments and there are no known medications that can be used clinically to prevent noise-induced hearing loss in humans. The long-term goal of this research is to find medications that can prevent noise-induced hearing loss. The purpose of the present pilot study is to evaluate zonisamide and methylprednisolone as medications to prevent temporary transient hearing loss in humans.

Key facts

Study ID

NCT02049073

Run by

Washington University School of Medicine

People needed

0

Starts

2017-10-31

Expected to finish

2017-11-01

Last updated by the study team

2017-11-06

Who can join

Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• adults 18 to 30 years old
• normal hearing
• good to excellent health

You may not qualify if…

• hearing loss
• history of seizures
• history of allergy or hypersensitivity to sulfonamide or oral steroid medications

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.